🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA The UK-India CETA: A Deep Dive into Bilateral Pharmaceutical Value Chains, API Trade, and Medicine Price Trajectories Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors Normalization or Correction? Ireland’s Goods Exports Drop 29% in May as Pharma Surplus Narrows Pilot Photonics Secures €10.4 Million EIC Accelerator Funding to Scale Deeptech Photonic Chips Intel Announces €5 Billion ($5.7 Billion) AI-Driven Semiconductor Expansion at Leixlip, Kildare University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026 After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA The UK-India CETA: A Deep Dive into Bilateral Pharmaceutical Value Chains, API Trade, and Medicine Price Trajectories Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors Normalization or Correction? Ireland’s Goods Exports Drop 29% in May as Pharma Surplus Narrows Pilot Photonics Secures €10.4 Million EIC Accelerator Funding to Scale Deeptech Photonic Chips Intel Announces €5 Billion ($5.7 Billion) AI-Driven Semiconductor Expansion at Leixlip, Kildare University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
18 results for “portugal”
MedicineActive substanceLicence holderStatus
Atracurium 10 mg/ml solution for injection/infusion
PA1217/011/001
Atracurium besilate Hikma Farmacêutica (Portugal) S.A. Not marketed
Ceftazidime 1 g powder for solution for injection/infusion
PA1217/012/002
Ceftazidime Hikma Farmacêutica (Portugal) S.A. Not marketed
Ceftazidime 2 g powder for solution for injection/infusion
PA1217/012/003
Ceftazidime Hikma Farmacêutica (Portugal) S.A. Not marketed
Ceftazidime 500 mg powder for solution for injection
PA1217/012/001
Ceftazidime Hikma Farmacêutica (Portugal) S.A. Not marketed
Imipenem/Cilastatin 500 mg/500 mg powder for solution for infusion
PA1217/005/001
Imipenem monohydrate, Cilastatin sodium Hikma Farmacêutica (Portugal) S.A. Not marketed
Levofloxacin 5 mg/ml solution for infusion
PA1217/008/001
Levofloxacin Hikma Farmacêutica (Portugal) S.A. Not marketed
Levofloxacin 5 mg/ml solution for infusion
PA1217/008/002
Levofloxacin Hikma Farmacêutica (Portugal) S.A. Not marketed
Meropenem 1g powder for solution for injection/infusion
PA1217/006/002
Meropenem Hikma Farmacêutica (Portugal) S.A. Marketed
Meropenem 2 g powder for solution for injection/infusion
PA1217/006/003
Meropenem Trihydrate Hikma Farmacêutica (Portugal) S.A. Not marketed
Meropenem 500 mg powder for solution for injection/infusion
PA1217/006/001
Meropenem Hikma Farmacêutica (Portugal) S.A. Marketed
Teicoplanin Hikma 100 mg powder for solution for injection/infusion
PA1217/010/003
Teicoplanin Hikma Farmacêutica (Portugal) S.A.
Teicoplanin Hikma 200 mg Powder for solution for injection/infusion or oral solution
PA1217/010/001
Teicoplanin Hikma Farmacêutica (Portugal) S.A. Not marketed
Teicoplanin Hikma 400 mg Powder for solution for injection/infusion or oral solution
PA1217/010/002
Teicoplanin Hikma Farmacêutica (Portugal) S.A. Not marketed
Truoxin I.V. 200mg/100ml solution for infusion
PA1217/002/001
Ciprofloxacin Hikma Farmacêutica (Portugal) S.A. Marketed
Truoxin I.V. 400 mg/200 ml solution for infusion
PA1217/002/002
Ciprofloxacin Hikma Farmacêutica (Portugal) S.A. Marketed
Vancomycin 1000 mg Powder for concentrate for solution for infusion
PA1217/009/002
VANCOMYCIN HYDROCHLORIDE Hikma Farmacêutica (Portugal) S.A. Not marketed
Vancomycin 500 mg Powder for concentrate for solution for infusion
PA1217/009/001
VANCOMYCIN HYDROCHLORIDE Hikma Farmacêutica (Portugal) S.A. Not marketed
Voriconazole Hikma 200 mg powder for solution for infusion
EU/1/15/1004/001-002
Voriconazole Hikma Farmacêutica (Portugal) S.A.
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 23 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.